Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9605018 Substituted nucleotide analogs

Patent 9605018 was granted and assigned to Alios BioPharma, Inc. on March, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
Alios BioPharma, Inc.
Date Filed
January 29, 2015
Date of Patent
March 28, 2017
Patent Applicant
‌
Alios BioPharma, Inc.
Patent Application Number
14608523
Patent Citations Received
‌
US Patent 12012431 Methods of preparing 1′-cyano nucleosides
0
‌
US Patent 11939347 1′-cyano nucleoside analogs and uses thereof
0
‌
US Patent 11975017 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
0
‌
US Patent 11975012 Remdesivir treatment methods
0
‌
US Patent 11660307 Methods for treating SARS CoV-2 infections
0
‌
US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
0
‌
US Patent 11780844 Compounds and methods for treatment of viral infections
‌
US Patent 11851438 1′-cyano nucleoside analogs and methods for treatment of viral infections
0
‌
US Patent 11903953 Remdesivir treatment methods
0
‌
US Patent 11926645 Compounds and methods for treatment of viral infections
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9605018
Patent Primary Examiner
‌
Lawrence E Crane

Find more entities like US Patent 9605018 Substituted nucleotide analogs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo